Status:
COMPLETED
PreHospital Air Medical Plasma Trial
Lead Sponsor:
Jason Sperry
Collaborating Sponsors:
University of Texas
University of Louisville
Conditions:
Hemmorhagic Shock During Air Medical Transport
Eligibility:
All Genders
18-90 years
Phase:
PHASE3
Brief Summary
To determine the effect of the prehospital infusion during air transport of 2 units of AB plasma on 30 day mortality in patients with hemorrhagic shock as compared to conventional care.
Detailed Description
Background: Although advances in the care of the severely injured patient have occurred over the last decade, patients continue to be plagued with uncontrolled hemorrhage resulting in significant earl...
Eligibility Criteria
Inclusion
- Hemorrhagic shock not responsive to crystalloid infusion -
Exclusion
- Isolated Fall, Cervical cord injury, prisoner, pregnant patient, traumatic arrest
- \-
Key Trial Info
Start Date :
May 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
523 Patients enrolled
Trial Details
Trial ID
NCT01818427
Start Date
May 1 2014
End Date
September 1 2017
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213